Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
HQDJpV8nU1VnRwKe